Core Viewpoint - The 2025 BCEIA exhibition showcased significant innovations in chromatography technology, emphasizing efficiency, intelligence, and application-oriented solutions in the industry [4][22]. Company Highlights - **Wanyi Technology**: Launched the LC3500 series liquid chromatography system featuring a new high-pressure infusion system with a maximum pressure of 1500 bar and an intelligent temperature control system with precision of ±0.1℃ [7]. - **Qingdao Shenghan**: Presented the CIC-D180H and CIC-D200E high-pressure ion chromatography instruments, along with the CLC-3200 ultra-high-performance liquid chromatography system, which boasts high accuracy and low cross-contamination [9]. - **Haineng Technology (Wukong Instruments)**: Introduced the CMC-ligand/receptor interaction analyzer for analyzing ligand-receptor interactions, and a complex target analysis instrument combining cell membrane chromatography with liquid chromatography [12][13]. - **Dima Technology**: Showcased a full range of chromatography columns and specialized columns for various applications, including a unique mixed-mode liquid chromatography column [15]. - **Shimadzu**: Celebrated its 150th anniversary by unveiling the GC2050 gas chromatography product and the new i-Series liquid chromatography systems, highlighting innovations tailored for petrochemical analysis [17]. - **Yizhen Analysis**: Displayed customized application solutions based on chromatography technology, including various specialized instruments [19]. - **Nanwei Technology Group**: Exhibited a range of chromatography products across its sub-brands, showcasing a complete solution from chromatography consumables to data processing systems [21]. Industry Trends - The focus of chromatography technology is shifting from hardware breakthroughs to application-driven solutions, with companies developing specialized instruments and methods to meet specific industry needs [22]. - The domestic ultra-high-performance chromatography market is gaining momentum, with products like Wanyi's LC3500 and Qingdao Shenghan's CLC-3200 enhancing competition in the market [22]. - Collaboration across the industry is becoming a new engine for development, with partnerships like Haineng Technology's collaboration with Xi'an Jiaotong University exemplifying the push towards integrated innovation [23]. - The integration of intelligent and automated technologies into chromatography systems is advancing, as seen in Wanyi's SmartLab CDS workstation and Shimadzu's i-Series design, facilitating the digital transformation of laboratories [23].

Core Viewpoint - Chromatography technology is a crucial analytical method driving scientific breakthroughs and industrial upgrades, with advancements in multidimensional, combined, and intelligent applications across various fields such as life sciences, environmental monitoring, food safety, and precision medicine [1][2]. Event Overview - The 10th Chromatography Network Conference (iCC 2025) will be held on September 4-5, 2025, organized by Instrument Information Network in collaboration with the North American Chinese Chromatography Association (CACA) [1][3]. Conference Focus Areas - The conference will feature four main sessions: 1. Cutting-edge technology session focusing on innovative chromatographic methods [1]. 2. Food and environmental applications session addressing new standards and applications in PFAS detection, carbohydrate analysis, and food flavor analysis [1]. 3. Pharmaceutical research session with insights from renowned pharmaceutical scientists on drug development and quality control challenges [1]. 4. Domestic chromatography technology session showcasing breakthroughs from local enterprises [1]. Conference Schedule Highlights - September 4: - Presentations on low-abundance compound analysis, innovative gas chromatography applications, and therapeutic protein drug analysis [4]. - Afternoon sessions on PFAS analysis and new standards for environmental air particulate matter [4]. - September 5: - Focus on pharmaceutical research with discussions on nitrosamine risks in drugs and quality control methods for protein drugs [5]. - A showcase of domestic chromatography technology and applications, highlighting the achievements of local companies [5]. Notable Speakers - The conference will feature experts from various institutions, including: - Professor Feng Yuqi from Wuhan Textile University, specializing in chromatographic applications [7]. - Professor Huang Jun from Tsinghua University, focusing on PFAS analysis methods [8]. - Senior Scientist Nan He from AbbVie, discussing nitrosamine risks in pharmaceuticals [8].

Core Viewpoint - Jiangsu Hanbang Technology has initiated its IPO, leveraging policy support and market demand, with a focus on core technology and high R&D investment to expand production capacity and R&D centers, promoting domestic substitution and innovation in chromatography separation and purification equipment [1][3]. Group 1: Company Overview - Jiangsu Hanbang Technology Co., Ltd. specializes in the R&D, production, and sales of chromatography technology, widely applied in pharmaceuticals and life sciences [4]. - The company is one of the earliest in China to master complete proprietary liquid chromatography system technology, covering all stages from laboratory to industrial production and various drug categories [4]. - Hanbang Technology ranks second in the production-grade liquid chromatography separation equipment market in China, with a market share of approximately 12.7% [4]. Group 2: Market Dynamics - The Chinese liquid chromatography equipment market exceeded 2.7 billion yuan in 2023, with Hanbang holding significant market shares of 39.2% in small molecule liquid chromatography systems and 8.8% in macromolecule chromatography systems [4]. - The chromatography equipment market has surpassed 10 billion yuan, driven by increasing global demand, domestic market expansion, and supportive national policies [4]. Group 3: R&D and Innovation - Hanbang Technology has invested significantly in R&D, with expenditures rising from 2,204,120 yuan in 2021 to 4,184,600 yuan in 2024, reflecting a strong commitment to technological innovation [5]. - The company has obtained 53 invention patents, including 40 domestic and 13 overseas patents, showcasing its strong R&D capabilities [5]. Group 4: IPO Fund Utilization - The funds raised from the IPO will be primarily allocated to expand production capacity and enhance R&D center construction [5][6]. - Specific projects include the production of 1,000 units of liquid chromatography series separation equipment and the establishment of a chromatography separation equipment R&D center [6][7]. - These initiatives aim to solidify Hanbang's leadership position in the industry and promote high-quality development [8].